Lynn McRoy
Impact in
-
- Advanced Breast Cancer Therapies
- Cancer-related cognitive impairment studies
- Cardiovascular and Diving-Related Complications
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Advanced Breast Cancer Therapies 45
- Oncology 30
- HER2/EGFR in Cancer Research 15
- Cancer-related Molecular Pathways 12
- Cancer Treatment and Pharmacology 5
- Co-authors
- Adam Brufsky (26 shared papers)Xianchen Liu (21 shared papers)Rachel M. Layman (20 shared papers)Hope S. Rugo (17 shared papers)Benjamin Li (19 shared papers)Richard S. Finn (5 shared papers)Massimo Cristofanilli (7 shared papers)Angela DeMichele (8 shared papers)
- Journals
- Annals of Oncology (7 papers)Cancer Research (6 papers)Future Oncology (5 papers)Journal of Clinical Oncology (5 papers)ESMO Open (3 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Lynn McRoy
46 papers receiving 608 citations
Peers
Comparison fields: 5 of 54
- Pulmonary and Respiratory Medicine 531
- Oncology 429
- Cancer Research 229
- Genetics 155
- Internal Medicine 11
Countries citing papers authored by Lynn McRoy
This map shows the geographic impact of Lynn McRoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn McRoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn McRoy more than expected).
Fields of papers citing papers by Lynn McRoy
This network shows the impact of papers produced by Lynn McRoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn McRoy. The network helps show where Lynn McRoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Lynn McRoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 111 | |
| 2 | 2021 | 85 | |
| 3 | 2022 | 68 | |
| 4 | 2018 | 54 | |
| 5 | 1991 | 25 | |
| 6 | 2021 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 20 | |
| 10 | 2022 | 16 | |
| 11 | 2023 | 16 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2025 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2023 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 6 |
About Lynn McRoy
Lynn McRoy is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Economics and Econometrics and Genetics, having authored 50 papers that have together received 617 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (45 papers), Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (15 papers), Cancer-related Molecular Pathways (12 papers), Cancer Treatment and Pharmacology (5 papers), Economic and Financial Impacts of Cancer (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (531 citations), Oncology (429 citations), Cancer Research (229 citations), Genetics (155 citations) and Internal Medicine (11 citations). Lynn McRoy has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Adam Brufsky, Xianchen Liu, Rachel M. Layman, Hope S. Rugo, Benjamin Li, Richard S. Finn, Massimo Cristofanilli, Angela DeMichele, Mylin A. Torres and Jack Mardekian. Their work appears in journals such as Annals of Oncology, Cancer Research, Future Oncology, Journal of Clinical Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.